NO20042666L - Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer - Google Patents

Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer

Info

Publication number
NO20042666L
NO20042666L NO20042666A NO20042666A NO20042666L NO 20042666 L NO20042666 L NO 20042666L NO 20042666 A NO20042666 A NO 20042666A NO 20042666 A NO20042666 A NO 20042666A NO 20042666 L NO20042666 L NO 20042666L
Authority
NO
Norway
Prior art keywords
cytochrome
combination
protease inhibitors
dependent protease
dependent
Prior art date
Application number
NO20042666A
Other languages
English (en)
Norwegian (no)
Inventor
Ronald Van Der Geest
Paul Stoffels
Cornelis Groen
Dirk Edward Desire Jochmans
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042666(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20042666L publication Critical patent/NO20042666L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20042666A 2001-12-12 2004-06-24 Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer NO20042666L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204841 2001-12-12
PCT/EP2002/014277 WO2003049746A2 (en) 2001-12-12 2002-12-12 Combination of cytochome p450 dependent protease inhibitors

Publications (1)

Publication Number Publication Date
NO20042666L true NO20042666L (no) 2004-09-09

Family

ID=8181408

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042666A NO20042666L (no) 2001-12-12 2004-06-24 Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer

Country Status (27)

Country Link
US (1) US20050119338A1 (es)
EP (1) EP1458447B1 (es)
JP (1) JP2005511723A (es)
KR (1) KR100974921B1 (es)
CN (1) CN100335060C (es)
AR (1) AR037797A1 (es)
AT (1) ATE442189T1 (es)
AU (1) AU2002358713B2 (es)
BR (1) BR0215043A (es)
CA (1) CA2469343C (es)
CY (1) CY1110604T1 (es)
DE (1) DE60233677D1 (es)
DK (1) DK1458447T3 (es)
ES (1) ES2333206T3 (es)
HR (1) HRP20040619A2 (es)
HU (1) HUP0402644A3 (es)
IL (1) IL162353A0 (es)
MX (1) MXPA04005755A (es)
NO (1) NO20042666L (es)
NZ (1) NZ533826A (es)
PL (1) PL373072A1 (es)
PT (1) PT1458447E (es)
RU (1) RU2329050C2 (es)
SI (1) SI1458447T1 (es)
TW (1) TWI286476B (es)
WO (1) WO2003049746A2 (es)
ZA (1) ZA200404633B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1670773T3 (pl) * 2003-09-30 2007-06-29 Tibotec Pharm Ltd Sposób wytwarzania sulfonamidów benzoksazolu i ich związków pośrednich
AU2004308712A1 (en) * 2003-12-23 2005-07-14 Tibotec Pharmaceuticals Ltd. Self-microemulsifying drug delivery systems of a HIV protease inhibitor
MXPA06012909A (es) * 2004-05-07 2007-09-06 Sequoia Pharmaceuticals Inc Inhibidores de proteasa retroviral repelente de resistencia.
CN1984654A (zh) * 2004-07-08 2007-06-20 泰博特克药品有限公司 抗－hiv逆转录酶和蛋白酶抑制剂的组合
AU2006217922B2 (en) 2005-02-25 2012-04-05 Janssen Sciences Ireland Uc Protease inhibitor precursor synthesis
JP2008538354A (ja) * 2005-04-08 2008-10-23 キメリクス，インコーポレイテッド ウイルス感染症およびその他の内科疾患を治療するための化合物、組成物および方法
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
AR058238A1 (es) * 2005-11-28 2008-01-23 Tibotec Pharm Ltd Compuestos y derivados de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
TWI385173B (zh) * 2005-11-28 2013-02-11 Tibotec Pharm Ltd 作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物
BRPI0620865A2 (pt) * 2005-12-30 2011-11-29 Gilead Sciences Inc métodos para melhorar a farmacocinética de inibidores das integrases do hiv
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
US8048871B2 (en) 2006-08-18 2011-11-01 Sequoia Pharmaceuticals, Inc. Compositions and methods for inhibiting cytochrome P450
EP2139883A4 (en) * 2007-03-23 2011-06-22 Univ Massachusetts HIV-1 protease inhibitor
UA103013C2 (uk) 2007-12-06 2013-09-10 Тиботек Фармасьютикелз Амідні сполуки як активатори противірусних препаратів
GT200800303A (es) * 2007-12-24 2009-09-18 Combinacion anti-retroviral
CN101977610B (zh) 2008-01-25 2012-05-16 奇默里克斯公司 治疗病毒感染的方法
US8664391B2 (en) 2008-10-07 2014-03-04 Janssen R&D Ireland Ltd Amide compounds as boosters of antivirals
US8921349B2 (en) 2009-05-11 2014-12-30 Purdue Research Foundation Compounds and methods for treating AIDS and HIV infections
JO3090B1 (ar) * 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
PT2534150T (pt) 2010-02-12 2017-05-02 Chimerix Inc Métodos para tratar uma infecção viral
US9278135B2 (en) 2010-04-26 2016-03-08 Chimerix Inc. Methods of treating retroviral infections and related dosage regimes
EP2576544A4 (en) * 2010-06-01 2013-09-11 Angion Biomedica Corp INHIBITORS OF CYTOCHROMES P450 AND USES THEREOF
HUE030341T2 (en) 2011-07-07 2017-05-29 Janssen Sciences Ireland Uc Darunavir preparations
SI2729130T1 (en) 2011-07-07 2018-03-30 Janssen Sciences Ireland Uc Combined formulations of darunavir

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010281A1 (en) * 1993-10-13 1995-04-20 Merck & Co., Inc. Combination therapy for hiv infection
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
ES2262184T3 (es) * 1996-08-05 2006-11-16 Myriad Genetics, Inc. Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion.
US6180634B1 (en) * 1997-11-13 2001-01-30 Merck & Co., Inc. Combination therapy for the treatment of AIDS
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
JP4776775B2 (ja) * 1998-06-23 2011-09-21 アメリカ合衆国 Ｈｉｖ感染哺乳動物を治療するための医薬組成物
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
EP1159278B1 (en) * 1999-02-12 2005-11-30 Vertex Pharmaceuticals Incorporated Inhibitors of aspartyl protease
TWI260322B (en) * 1999-02-12 2006-08-21 Vertex Pharma Inhibitors of aspartyl protease

Also Published As

Publication number Publication date
CA2469343A1 (en) 2003-06-19
ZA200404633B (en) 2005-09-01
WO2003049746A3 (en) 2003-12-31
TWI286476B (en) 2007-09-11
CN100335060C (zh) 2007-09-05
SI1458447T1 (sl) 2010-01-29
HRP20040619A2 (en) 2005-08-31
RU2329050C2 (ru) 2008-07-20
IL162353A0 (en) 2005-11-20
RU2004121144A (ru) 2005-04-20
WO2003049746A2 (en) 2003-06-19
NZ533826A (en) 2006-04-28
HK1070008A1 (en) 2005-06-10
PT1458447E (pt) 2009-12-16
DK1458447T3 (da) 2010-01-18
HUP0402644A3 (en) 2008-04-28
HUP0402644A2 (en) 2007-02-28
CY1110604T1 (el) 2015-04-29
ES2333206T3 (es) 2010-02-18
CA2469343C (en) 2008-05-13
AU2002358713B2 (en) 2009-01-29
MXPA04005755A (es) 2004-09-10
TW200409624A (en) 2004-06-16
KR20040071182A (ko) 2004-08-11
JP2005511723A (ja) 2005-04-28
EP1458447B1 (en) 2009-09-09
BR0215043A (pt) 2004-11-03
CN1604803A (zh) 2005-04-06
DE60233677D1 (de) 2009-10-22
AU2002358713A1 (en) 2003-06-23
EP1458447A2 (en) 2004-09-22
KR100974921B1 (ko) 2010-08-09
PL373072A1 (en) 2005-08-08
AR037797A1 (es) 2004-12-01
US20050119338A1 (en) 2005-06-02
ATE442189T1 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
ATE442189T1 (de) Kombination von cytochrom-p450-abhängigen protease-inhibitoren
NO20041180L (no) Pyrrolopyrimidiner som midler for inbibering av cysteinprotaser
CY2015028I1 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
PL373399A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
DE60233399D1 (de) Erzerrung zweiter ordnung
DE60238291D1 (de) Wafer-Haltevorrichtung
PL375486A1 (en) Potent inhibitor of hcv serine protease
DE60234125D1 (de) E inhibitoren
CY2012007I1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
NO20034044L (no) Metallproteinase-inhibitorer
DE60230934D1 (de) Fab-i-inhibitoren
ATE357432T1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
NO20034032D0 (no) Metallproteinase-inhibitorer
FI20010558L (fi) Kappaleiden paikannus
DE60232067D1 (de) 2-amino-benzoxazol-suphonamide als breitspektrum-hiv-protease-inhibitoren
NO20025786L (no) Protaseinhibitorer
DE60226715D1 (de) Monoamin-aufnahme-inhibitor
NO20025005L (no) Proteaseinhibitorer
EP1401453A4 (en) PROTEASE INHIBITORS
AU2002348465A1 (en) Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
FI20012295A0 (fi) Hyvyysluku
NO20032328L (no) Proteaseinhibitorer
DE60124397D1 (de) Inhibitoren von serinproteasen
NO20013036L (no) HC-dekkgass
ITBA20010029U1 (it) Gioiello di puglia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application